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The history and operational results in the six years since the Kidney 
Stone Center of the Pacific opened in 1986 are summarized and 
compared to the published literature, with particular attention to 
Hawaii's unique racial composition. We hope that the results will 
enable us to improve our management of stones in the future. 
Background 
The Kidney Stone Center of the Pacific began operations in 
December 1986; by the end of 1993, a total of 2,945 patients had 
been treated. The Kidney Stone Center of the Pacific is a coopera-
tive venture of three entities: Kuakini Development Corporation, 
Queen's Health Technologies and Straub Imaging Services, all 
located in Honolulu. 
In the mid 1980s the Domier company of Germany developed the 
extracorporeal shock wave lithotriptor (ESWL).1 This machine 
used shock waves generated by a large spark-plug-like device 
transmitted through water to fragment kidney stones, which could 
then be passed as sand-like particles through the ureter. The shock 
waves are aimed by using fluoroscopy to visualize the stone and are 
controlled by the patient's electrocardiogram (Fig 1). 
Before this time, stones usually had to be removed by incising the 
patient, which required hospitalization and a long period of conva-
lescence. Complications of surgery included bleeding, infection, 
and urinary leakage. 
Lithotripsy represented a revolution in the treatment of stones; 
now patients could be treated as outpatients and the risk of compli-
cations was greatly reduced. Urologists in Hawaii saw the benefits 
of the machine and discussed how to obtain one to serve the Pacific. 
However, several obstacles had to be overcome. 
The cost of the machine was $1.5 million, not including the space 
and support equipment, which brought the total cost to about $3 
million. At one point a partnership of urologists was considered that 
would purchase, set up, and operate the machine, but that was 
rejected as being impracticable. Instead, interested hospitals were 
invited to participate. All of the hospitals on Oahu were asked to 
participate; finally, three hospitals contributed equal amounts of 
capital and combined their expertise to form the Kidney Stone 
Center of the Pacific. Each partner contributed support; for ex-
ample, Kuakini was responsible for marketing, Queen's for sched-
uling and operations, and Straub for the business plan. 
The location of the lithotriptor was the subject of much discussion. 
At first, a neutral site was considered; however, this was impracti-
cable because ancillary services such as cystoscopy, x-ray, and 
post-anesthetic recovery were required. This meant a hospital site 
was needed, and Queen's was selected. 
Meanwhile, a state review process by the State Health & Phar-
macy Development Agency (SHPDA) was required. At first, there 
was skepticism by the board that there was a need for a machine. 
However, thanks to testimony by the urologists and hospitals, 
approval was granted and construction began. 
On December 10, 1986, the first patient was treated on the Domier 
HM-3. The originallithotriptor, now seven years old, continues to 
serve Hawaii and the Pacific today. It represents an example of the 
benefits of a cooperative, rather than competitive and more costly, 
approach to health care in Hawaii. 
Review of Operations 1986 to 1993 
Data Analysis 
Patient records have been maintained on a personal computer 
using the Q & A data base since the Kidney Stone Center began 
operations. Standardized reporting forms permitted the collection 
of data in a systematic manner. The data was extracted on the 
computer using different criteria. Of course, the data retrieved is 
only as good as the data input, which is why it was important to 
complete the forms as thoroughly as possible. 
Total Patients Treated 
The total number of patients treated from December 10, 1986 to 
December 31, 1993 was 2,945 or about 500 patients a year (Fig 2). 
The total number of patients treated has remained fairly constant 
over the years. There was not a great monthly variation in patients 
treated. This information has been useful in planning for staffing 
and equipment allocation. Compared to national statistics, in a study 
of more than one million patients, Hawaii had a stone rate of 8.2 
which was about average for the nation.2 
Age of Patients 
The oldest patient treated was 92 years old; the youngest, 4 years 
and 9 months. The average age of the patients was 43, with a mean 
of 40 years. Very young patients, because of their small stature, 
required a special arrangement of the lithotriptor gantry. Other than 
that, no special techniques were required for patients because of 
their age. 
Gender 
Sixty percent of the patients were male and 40% were female, 
which is in keeping with published statistics for stones. The litera-
ture reports that up to 70% of patients were male.3 
Race 
Hawaii has a unique mixture of races. In fact, in analyzing the 
data, many times determining the race of the patient was a problem 
because of the number of ethnic backgrounds. Of the patients treated 
at the Kidney Stone Center, the majority were Caucasian. It is 
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Fig 1.-Schematic of lithotriptor 
interesting to compare the observed incidence of stones with the 
population makeup of the state (Fig 3). For example, Caucasians 
accounted for 34.16% of the general population in the 1990 census 
and represented 34.35% of the stones. Filipinos were overrepre-
sented, comprising 15.59% of the state population, they accounted 
for 20.41% of the stones. The Japanese, Chinese, and Hawaiians 
were underrepresented. 
Source of Patients 
The lithotriptor serves the Pacific region including islands in the 
South Pacific. Non-Hawaii residents accounted for 10.6% of the 
treatments, including patients from the continental United States, 
Pacific Islands, Japan, Australia, American Samoa, Guam, and 
Canada. 
Location of Calculi 
Renal calculi accounted for 84% of the stones, with ureteral 
calculi representing 15.6% of the stones. Single stones were found 
in 69% of the patients, with multiple stones in one kidney in 21%. 
Single stones in both kidneys were 5% of the group, with multiple 
stones in both kidneys found in another 5%. Again, this is in 
accordance with ranges found in the published literature.2·6 
Size of Calculi 
The calculi ranged in size from <I em to >9 em, and as expected, 
there were more smaller stones. The size of the stone is significant 
because the larger stone requires more shocks than the smaller one, 
thereby increasing the patient's exposure to shock wave energy and 
greater complications. In fact, some larger staghom calculi can be 
treated best with percutaneous nephrostolithotomy, in which the 
calculi are removed through a small opening in the patient's back. 
As expected, the smaller stones were more prevalent. 
Number of Shocks 
The amount of energy varied. The mean was 21 kV with a range 
of 14 k V to 28 k V. The number of shocks ranged from 300 to >5000 
per treatment, and the median number of shocks was 1,500 to 2,000. 
Generally, the larger the stone, the more shocks required. Some 
stones, such as uric acid stones, are harder and require more shocks. 
The number of shocks was less for smaller stones and increased as 
the stone size increased, but seemed to stabilize at about 2,500 to 
2, 700 shocks in the range from 4 em to 9 em. 
-
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Fig 2.-Annual treatment load 
Types of Stones 
Stone analysis was incomplete because many of the patients had 
no data that could be gleaned from the records. This is expected 
because the data is pretreatment and, of course, stone analysis has 
not yet been performed. Of the 656 cases that could be evaluated, 
77% had calcium oxalate, 16% uric acid, and 7% struvite. A large 
study indicates that the Mainland incidence of the different types of 
calculi are 80% calcium oxalate, 7% struvite, and only 3% each of 
uric acid, cystine, and calcium phosphate.2 It is interesting to note 
the racial differences in relation to the type of stone (Fig 4). The only 
other study from Hawaii addressing this issue was published in 
1970.7 In this study, it was noted that Tripier Army Medical Center 
patients, who were 82% Caucasian, had only 2% uric acid calculi, 
while patients at St Francis Medical Center, who were 29% Cauca-
sian, had a 29% rate of uric acid stones. When broken down, uric 
acid stones accounted for 30% of the stones among the Chinese, 
Japanese, and Filipino population. This compared to the 14% rate of 
uric acid stones in Caucasian patients at St Francis Medical Center. 
The authors noted this and suggested diet could have played a role. 
Our experience more than 20 years later seems to indicate that we 
are seeing fewer uric acid calculi since the overall rate among the 
general population was 16%. However, that is still high by national 
standards. It is interesting to note that the Filipino and Chinese rates 
of uric acid stones were low, while the rate among Japanese and 
Hawaiian patients was significantly higher. We can only speculate 
about the reason for this, but diet might still be a factor. 
Retreatments and Complications 
Retreatments accounted for 10.7% of the cases. This is in line with 
the reported literature, which reports a retreatment rate of 9% to 
17%.3-6 
The rate of retreatment is particularly important because it illus-
trates the degree of effectiveness of treatment. We believe our 
figures are accurate because there is only one site for treatment with 
ESWL in the state. 
Complications have been low,less than I%. They have included 
occasional pain and nausea; however, there have been no deaths 
directly attributable to ESWL. 
Radiation Exposure of Personnel 
One of the concerns of treatment was the exposure of the staff and 
physicians to radiation with the use of fluoroscopy and snapshots. 8 
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Radiation exposure using fluoroscopy was measured by the amount 
of time and number of snapshots. This ranged from <1 minute to 
> 16 minutes, the mean was about 3 minutes. The number of 
snapshots taken ranged from 0 to 55 and more, which compares well 
with published reports from other facilities. 
The radiation exposure delivered to the patient can be calculated 
from the fluoroscopy time and number of snapshots using measured 
radiation output. From the above data, the patient exposures ranged 
from 0.04 Gy to .21 Gy with an average of .12 Gy. This is similar 
to the dose delivered during other fluoroscopic procedures, such as 
an upper gastrointestinal barium study. 
The walls and water of the stainless steel tub attenuate the scatter 
radiation quite effectively. This means that the radiation exposure 
in the vicinity of the ESWL tub is negligible, and the staff is not 
required to wear lead aprons during the procedure. 
We have used the radiation usage and exposure for individual 
physicians in order to increase awareness and enable more efficient 
use of x-rays. 
Future Studies 
Our data collection has given us insight into how the Kidney Stone 
Center has been performing, and the retreatment rate of 10.7% falls 
within generally accepted standards. In the future, we will be 
focusing more on post-treatment outcomes. We have instituted a 
program offollow-up phone calls to the patients to assess their state 
after the treatment, focusing not only on the effects of lithotripsy, 
but on anesthetic effects. In this way we hope to improve patient 
care at the Center. 
Summary 
The Kidney Stone Center, now more than seven years old, has 
served Hawaii well. It has fulfilled its mission of serving the people 
in Hawaii and the Pacific Basin. During its tenure, it has provided 
state-of-the-art treatment and improved patient care; it has resulted 
in a significant net savings in patient discomfort, complications, lost 
work time, and hospitalization. It serves as a model for other 
cooperative ventures, especially in light of our limited geography 
and population. 
Technological progress has resulted in the production of newer 
lithotriptors that use different means of shock-wave generation and 
require less anesthesia or no anesthesia at alU The Kidney Stone 
Center is evaluating the feasibility of upgrading its lithotriptor. 
References 
1. Chaussy C, Schmied! E, Jocham D, Brendel W, Forsmann B, Walther V. First clinical experience with 
extracorporeally induced destruction of kidney stones by shock waves. J Urol. 1982;127:417. 
2. Soucie JM,Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and [eoqraphic variability ol 
kidiley stones ih the lfnifecfSlafes. Ki?firey ltJt. 1W4;46':em:899: 
3. Drach GW, Dretler S, Fair W, et al. Report ol the United States cooperative study of extracorporeal shock 
wave lithotripsy. J Urol. 1986: 135:1127. 
4. Graff J, Didlus W, Schulze H. Long-term followup in 1003 ESWL patients. J Urol. 1986;140:479. 
5. Fuchs G, Miller K, Rassweiler J, Eisenberger F. Extracorporeal shock wave l~hotripsy: one yeat 
experience with the Domier lithotriptor. Eur Uro/. 1985;11:145. 
6. Riehle RA, Fair WR, Vaughan ED, Jr. Extracorporeal shock wave lithotripsy for upper urinary tract 
calculi: One year's experience at a single center. JAMA. 1988; 255:204. 
7. Wurster JC, Ceccarelli FE, Jr, Chinn HYH. A comparative study of relative incidence of stone types 
between a transient mil~ population and the indigenous population o1 the Hawaiian Islands. J Urol. 
1970; 104:581. 
8. Lingeman JE, Newman D, Mertz JNO, et al. Extracorporeal shock wave ~thotripsy, the Methodist 
Hospital of Indiana experience. J Urol. 1984; 135:1134. 
9. Griffrth DP, Gleeson MJ, Politis G, GlazeS. Effectiveness of radiation control program for Domier HM3 
lithotriptor. Urology. 1989; 33:20.25. 
10. Rassweiler J, Aiken P. ESWL 90-state of the art Lim~tions and future trends of shock wave l~otripsy. 
Urol Res. 1990;18(suppi):S13-23. 
R etirement Pl ans How to live 
with someone 
who's living 
with cancer. 
mel r. hertz 
MBA, CFP 
• 
Investment M anagement 
Consulting 
• 
Life and Di sa bili ty 
Insurance 
• 
Charitable Remainder 
Trusts 
Certified Financial Planner 
Pacific Tower, Suite 2800 
100 1 Bishop Street 
Honolulu, Hawaii 96813 
(808) 599-4504 (d:)detand 
Socuriliooo Cllloor.d n-<po lfG ,...._.to s-.n.-. Inc. FQ, Motmbero NASO ...:1 SIPC. Flnanclol Pl..,."'s s..r.b. 
"'""""'" -.1 ~ Pt. ........ , Inc. WPJ, Lai-.1 '"-- ol.dvi- mol r.....,. • • nJi-.d princp.l 
ol FG """ ...... -.:1 Npn-u .. n. ol d.J • n ... " fP, .............. dl .. ""'-wn. un..tfiW.-d w~ d.wd. 
-
HAWAII MEDICAL JOURNAL, VOL 54, DECEMBER 1995 
818 
When one person gets 
cancer, everyone in the family 
suffers. 
Nobody knows better than 
we do how much help and 
understanding is needed. That's 
why our service and rehabili-
tation programs emphasize 
the whole family, not just the 
cancer patient. 
Among our regular services 
we provide information and 
guidance to patients and families, 
transport patients to and from 
treatment, supply home care 
items and assist patients in their 
return to everyday life. 
Life is what concerns us. The 
life of cancer patients. The lives of 
their families. So you can see we 
are even more than the research 
organization we are so well 
known to be. j· No one faces cancer alone. 
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